Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
expert
Dr Robert Hungerford
GP Supervisor with a special interest in Heart Failure, ASCVD and Diabetes, Marketown Health; Conjoint lecturer, University of Newcastle
